Herb & supplement monograph

N-acetyl Cysteine (nac) Drug Interactions, Uses, Effectiveness, Safety & More

Check N-acetyl Cysteine (nac) against your medication

Add one medication
N-acetyl Cysteine (nac)
+
Start typing any prescription or over-the-counter drug name.
Reviewed by licensed pharmacists Sourced from Natural Medicines

N-acetyl Cysteine (nac) Drug Interactions: The Bottom Line

From the HelloPharmacist Editorial Team · Updated July 2026

Based on the available evidence, the overall risk of a clinically significant N-acetyl Cysteine (nac) drug interaction appears low for most people, with one important exception involving nitroglycerin. Only one interaction is rated major, and nearly all of the rest are moderate concerns supported mainly by theoretical or early-stage research rather than human studies.

Interactions deserving the most attention

The combination that matters most is nitroglycerin given by IV or skin patch, where human research shows NAC can cause severe drops in blood pressure and intense headaches. People taking anticoagulant or antiplatelet drugs should also be careful, since some research shows NAC can slow clotting and reduce platelet activity, which could add to bleeding risk. NAC may also add to the effect of blood pressure medications, and it can work against activated charcoal when both are used, though these concerns rest on weaker evidence.

What the rest of the list means

NAC appears alongside a long list of medications, but that number does not mean every pairing is harmful. Most of these interactions are theoretical, drawn from animal or lab studies of possible effects on clotting, blood pressure, or absorption, and have not been confirmed to cause meaningful problems in people.

Check your medications against N-acetyl Cysteine (nac)

Based on HelloPharmacist’s N-acetyl Cysteine (nac) interaction data and reviewed under our editorial standards.

Interaction report

Drugs that interact with N-acetyl Cysteine (nac)

294 medications have a known interaction with N-acetyl Cysteine (nac), graded by severity. Select any drug for the full evidence-based detail.

1 major interaction. These combinations can be clinically significant — best avoided, or used only with close professional supervision. Always check with your pharmacist before combining them with N-acetyl Cysteine (nac).

2,830 drugs
NitroglycerinGonitro, Nitro Time, Nitro-Bid, Nitrocine Timecaps, Nitrogard, Nitrogard SR +7 more› AbciximabReoPro› AbrocitinibCibinqo› AcebutololRhotral, Sectral› AcenocoumarolSintrom› Acetaminophen, AspirinGemnisyn› Acetaminophen, Aspirin, CaffeineExcedrin, Excedrin Extra Strength, Excedrin Migraine› Acetaminophen, IbuprofenCombogesic› AcetazolamideAk-Zol, Diamox› Acetylsalicylic AcidEntrophen› AliskirenTekturna› Alteplase, TpaActilyse, Activase› Aluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium HydroxideAscriptin Codeine #2› Aluminum Hydroxide, Aspirin, Magnesium HydroxideAscriptin› AmbrisentanLetairis, Volibris› AmilorideAmilamont, Midamor› Amiloride, HydrochlorothiazideAmil-Co, Amilzide, Moduret 25, Moduretic› AmlodipineNorliqva› Amlodipine BenzoateKaterzia› Amlodipine BesilateIstin› Amlodipine BesylateNorvasc› Amlodipine Besylate, BenazeprilLotrel› Amlodipine, CelecoxibConsensi› Ammonium ChlorideAmmonium Chloride› Anacaulase-bcdbNexoBrid› AnagrelideAgrylin› AnisindioneMiradon› Antithrombin IiiThrombate III› ApixabanEliquis› AprocitentanTryvio›
Read The List Like a Pharmacist

What Severity, Likelihood & Evidence Mean

Severity — How Serious It Can Be

  • Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
  • Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
  • Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
  • No known interaction. Checked against our sources with nothing documented — not the same as proven safety.

Likelihood — How Well It’s Documented

  • Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
  • Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
  • Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
  • Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.

Where This Data Comes From

  • Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
  • Each drug listed above links to the full report for that exact N-acetyl Cysteine (nac) combination — clinical detail, likelihood, evidence level, and citations.
  • Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The big picture

The kinds of drugs N-acetyl Cysteine (nac) affects

Every type of medication (drug category) N-acetyl Cysteine (nac) is known to interact with. Open any category for the detail — or search your exact drug in the checker above.

All 5 drug categories N-acetyl Cysteine (nac) interacts with
NitroglycerinActivated CharcoalAnticoagulant/antiplatelet DrugsAntihypertensive DrugsChloroquine (aralen)
Nitroglycerin

N-acetyl cysteine can increase the risk for hypotension and headaches when taken with intravenous or transdermal nitroglycerin.
Clinical research shows that concomitant administration of N-acetyl cysteine and intravenous or transdermal nitroglycerin can cause severe hypotension and intolerable headaches. Furthermore, in vitro research suggests that N-acetyl cysteine increases the anticoagulant activity of nitroglycerin.

Likelihood Probable Evidence B
Activated Charcoal

N-acetyl cysteine might reduce the effects of activated charcoal, while activated charcoal might reduce the absorption of N-acetyl cysteine.
N-acetyl cysteine appears to reduce the capacity of activated charcoal to adsorb acetaminophen and salicylic acid. Conversely, although clinical research suggests that although activated charcoal can reduce the absorption of N-acetyl cysteine by up to 40%, it does not seem to reduce its clinical effects. Other clinical evidence suggests that activated charcoal does not affect the absorption of N-acetyl cysteine.

Likelihood Possible Evidence D
Anticoagulant/Antiplatelet Drugs

Theoretically, N-acetyl cysteine might increase the risk of bleeding when taken with anticoagulant or antiplatelet drugs.
Clinical research suggests that intravenous N-acetyl cysteine decreases prothrombin time, prolongs coagulation time, decreases platelet aggregation, and increases blood loss in surgical patients. Furthermore, in vitro research suggests that N-acetyl cysteine increases the anticoagulant activity of nitroglycerin.

Likelihood Possible Evidence D
Antihypertensive Drugs

Theoretically, N-acetyl cysteine might increase the risk of hypotension when taken with antihypertensive drugs.
Animal research suggests that N-acetyl cysteine potentiates the hypotensive effects of the angiotensin-converting enzyme inhibitors (ACEIs) captopril and enalaprilat. Theoretically, combining N-acetyl cysteine with other antihypertensive drugs might increase the risk of hypotension.

Likelihood Possible Evidence D
Chloroquine (Aralen)

Theoretically, N-acetyl cysteine might interfere with the antimalarial effects of chloroquine.
Animal research suggests that N-acetyl cysteine might reduce the antimalarial effects of chloroquine by increasing cellular levels of glutathione.

Likelihood Possible Evidence D
Monograph

N-acetyl Cysteine (nac): Uses, Safety & Side Effects

The bottom line

N-acetyl cysteine (NAC) is a supplement form of the amino acid cysteine and a building block for the antioxidant glutathione. It has well-established prescription uses for acetaminophen overdose and thinning mucus, but evidence for many over-the-counter uses is still limited. It is generally well tolerated, but you should check with a pharmacist or doctor before starting it.

N-acetyl Cysteine (nac)
Part used
Not applicable (a modified form of the amino acid cysteine)
Common forms
Capsules, tablets, powder, effervescent tablets, and prescription inhalation or injectable solutions
People commonly use it for
  • Thinning mucus in lung conditions
  • Acetaminophen (Tylenol) overdose treatment
  • Antioxidant and glutathione support
  • Liver support
  • Respiratory health

Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.

Safety at a glance
OverallUse caution

Generally well tolerated at typical doses, but talk to a healthcare provider before use.

PregnancyPossibly Safe

When used orally, intratracheally, intravenously, or by inhalation. N-acetyl cysteine crosses the placenta, but has not been associated with adverse e...

Read the full pregnancy detail
BreastfeedingInsufficient reliable information

Insufficient reliable information available; avoid using.

Read the full breastfeeding detail

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Jump to a section

Overview

N-acetyl cysteine (NAC) is a man-made form of the amino acid cysteine, which your body uses to make proteins and the important antioxidant glutathione. Unlike herbs, NAC does not come from a plant — it is made in a laboratory.

NAC has a long history as a prescription medicine. Doctors use it in hospitals to treat acetaminophen (Tylenol) overdose and to help loosen and thin thick mucus in people with certain lung problems. It is also sold as a dietary supplement, often marketed for antioxidant support, liver health, and respiratory wellness.

How it works

NAC supplies cysteine, a building block your body uses to make glutathione. Glutathione is one of the body's main antioxidants, helping protect cells from damage caused by oxidative stress.

In acetaminophen overdose, NAC helps the liver make more glutathione, which neutralizes the harmful byproduct that builds up and damages the liver. As a mucus-thinner, NAC is thought to break the chemical bonds that make mucus thick and sticky, making it easier to clear.

NAC may also have anti-inflammatory effects, but much of this work comes from laboratory and animal research, so the real-world importance for everyday supplement users is not yet clear.

Effectiveness

Does N-acetyl Cysteine (nac) work?

Evidence overview · 91 uses evaluated
4 Effective 11 Possibly effective 16 Leans ineffective 60 Insufficient evidence
How to read these evidence grades

Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.

1EffectiveStrong, consistent evidence it works.
2Likely EffectiveGood evidence, though not yet conclusive.
3Possibly EffectiveSome evidence suggests a benefit.
4Possibly IneffectiveSome evidence it may not help.
5Likely IneffectiveFairly strong evidence it doesn’t help.
6IneffectiveStrong evidence it doesn’t work.
7Insufficient Reliable Evidence to RateToo little research to say either way.
Effective Acetaminophen poisoning
Rating & evidence shown verbatim from Natural Medicines

Oral and intravenous N-acetyl cysteine, as prescription drug products, are effective for treating acetaminophen poisoning.

Effective Atelectasis
Rating & evidence shown verbatim from Natural Medicines

When inhaled, N-acetyl cysteine is effective for treating atelectasis.

Effective Bronchial diagnostic studies
Rating & evidence shown verbatim from Natural Medicines

When inhaled, N-acetyl cysteine is effective for bronchial diagnostic study preparation.

Effective Tracheostomy care
Rating & evidence shown verbatim from Natural Medicines

When inhaled and used as adjunct therapy, N-acetyl cysteine is effective for preventing endotracheal crusting in patients with a tracheostomy.

Possibly Effective Angina
Rating & evidence shown verbatim from Natural Medicines

Oral or intravenous N-acetyl cysteine may reduce nitroglycerin tolerance in patients with angina. However, some studies suggest that N-acetyl cysteine might increase the risk for severe headaches and hypotension when used with intravenous or transdermal nitroglycerin.

Possibly Effective Autism spectrum disorder
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine may improve irritability, but not other symptoms, associated with autism spectrum disorder.

Possibly Effective Bronchitis
Rating & evidence shown verbatim from Natural Medicines

Via inhalation, N-acetyl cysteine is FDA-approved for managing acute episodes of bronchitis. Oral N-acetyl cysteine may help to reduce the occurrence of acute exacerbations of chronic bronchitis when used for 3-36 months.

Possibly Effective Chronic obstructive pulmonary disease (COPD)
Rating & evidence shown verbatim from Natural Medicines

Taking N-acetyl cysteine orally seems to decrease the exacerbation rate and improve symptoms in patients with moderate to severe COPD, particularly those who are not taking inhaled corticosteroids. Also, taking N-acetyl cysteine along with standard therapy appears to improve recovery in patients hospitalized due to an acute exacerbation.

Possibly Effective Contrast induced nephropathy
Rating & evidence shown verbatim from Natural Medicines

Oral or intravenous administration of N-acetyl cysteine seems to prevent contrast induced nephropathy in patients with kidney dysfunction. However, it is not beneficial in those with normal kidney function or diabetes.

Possibly Effective Hyperhomocysteinemia
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine seems to reduce homocysteine levels.

Possibly Effective Hyperlipidemia
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine seems to reduce lipoprotein(a) levels.

Possibly Effective Ifosfamide (Ifex) toxicity
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine may be beneficial for reducing ifosfamide toxicity, although it does not appear to be as effective as mesna.

Possibly Effective Influenza
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine may reduce the risk for symptomatic influenza.

Possibly Effective Kidney failure
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine may reduce the risk for cardiovascular events in patients with kidney failure.

Possibly Effective Myocardial infarction (MI)
Rating & evidence shown verbatim from Natural Medicines

Intravenous N-acetyl cysteine, along with standard therapy, seems to improve outcomes in patients with MI. Oral N-acetyl cysteine has not been evaluated for this use.

Possibly Ineffective Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease)
Rating & evidence shown verbatim from Natural Medicines

Subcutaneous administration of N-acetyl cysteine does not seem to improve survival or disease progression in patients with ALS.

Possibly Ineffective Anthracycline cardiotoxicity
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to prevent or treat doxorubicin-induced cardiac toxicity.

Possibly Ineffective Bronchopulmonary dysplasia
Rating & evidence shown verbatim from Natural Medicines

Intratracheal N-acetyl cysteine does not seem to prevent bronchopulmonary dysplasia in premature infants.

Possibly Ineffective Cannabis use disorder
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to improve abstinence rates in patients with cannabis use disorder.

Possibly Ineffective Cystic fibrosis
Rating & evidence shown verbatim from Natural Medicines

Oral or inhaled N-acetyl cysteine does not seem to improve lung function in patients with cystic fibrosis.

Possibly Ineffective Erythropoietic protoporphyria (EPP)
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to improve photosensitivity in patients with EPP.

Possibly Ineffective Helicobacter pylori
Rating & evidence shown verbatim from Natural Medicines

Adding oral N-acetyl cysteine to conventional Helicobacter pylori (H. pylori) eradication regimens does not seem to increase eradication rates.

Possibly Ineffective Hepatitis
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not appear to improve treatment response in patients with hepatitis. However, when taken with interferon, it might lengthen the time to relapse.

Possibly Ineffective HIV/AIDS
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to increase CD4+ cell count in patients with HIV.

Possibly Ineffective Hypotension
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to improve renal outcomes in patients with prolonged hypotension.

Possibly Ineffective Liver transplant
Rating & evidence shown verbatim from Natural Medicines

Intravenous N-acetyl cysteine during liver donor operation does not seem to improve liver transplant outcomes. Oral N-acetyl cysteine has not been evaluated for this use.

Possibly Ineffective Pancreatitis
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to prevent pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP). Additionally, intravenous N-acetyl cysteine does not seem to reduce the risk of organ dysfunction in patients being treated for severe acute pancreatitis.

Possibly Ineffective Postoperative recovery
Rating & evidence shown verbatim from Natural Medicines

Oral or intravenous N-acetyl cysteine does not seem to improve survival, prevent complications, or reduce length of hospital stay in patients undergoing cardiac or liver surgery.

Likely Ineffective Head and neck cancer
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to reduce mortality, improve event-free survival, or prevent additional tumors in patients with head and neck cancer.

Likely Ineffective Lung cancer
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to reduce mortality, improve event-free survival, or prevent additional tumors in patients with lung cancer.

Likely Ineffective Multisystem organ failure
Rating & evidence shown verbatim from Natural Medicines

Administering intravenous N-acetyl cysteine might increase the risk of mortality due to multisystem organ failure. Oral N-acetyl cysteine has not been evaluated for this use.

Also studied for 60 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Acute respiratory distress syndrome (ARDS)
Rating & evidence shown verbatim from Natural Medicines

Research on the use of intravenous N-acetyl cysteine in patients with ARDS is conflicting. Oral N-acetyl cysteine has not been evaluated for this purpose.

Insufficient Reliable Evidence To Rate Adrenoleukodystrophy (ALD)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral or intravenous N-acetyl cysteine is beneficial in patients with ALD.

Insufficient Reliable Evidence To Rate Aging
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Alcohol-related liver disease
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral N-acetyl cysteine for preventing alcohol-related liver damage, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this purpose.

Insufficient Reliable Evidence To Rate Allergic rhinitis (hay fever)
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral N-acetyl cysteine for allergic rhinitis, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this condition.

Insufficient Reliable Evidence To Rate Altitude sickness
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine can treat or prevent altitude sickness.

Insufficient Reliable Evidence To Rate Alzheimer disease
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial for Alzheimer disease.

Insufficient Reliable Evidence To Rate Aminoglycoside ototoxicity
Rating & evidence shown verbatim from Natural Medicines

Small clinical studies suggest that oral N-acetyl cysteine may modestly reduce the risk of ototoxicity caused by aminoglycoside therapy.

Insufficient Reliable Evidence To Rate Asthma
Rating & evidence shown verbatim from Natural Medicines

It is unclear if inhaling N-acetyl cysteine is beneficial in patients with asthma.

Insufficient Reliable Evidence To Rate Athletic performance
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine can improve athletic performance.

Insufficient Reliable Evidence To Rate Biliary disorders
Rating & evidence shown verbatim from Natural Medicines

It is unclear if intravenous N-acetyl cysteine is beneficial in patients with biliary disorders. Oral N-acetyl cysteine has not been evaluated for this use.

Insufficient Reliable Evidence To Rate Bipolar disorder
Rating & evidence shown verbatim from Natural Medicines

The effects of oral N-acetyl cysteine in patients with bipolar disorder are conflicting. Oral N-acetyl cysteine might reduce symptoms of depression and increase remission rates, but it does not appear to be beneficial for reducing symptoms of mania or for maintaining remission.

Insufficient Reliable Evidence To Rate Bronchiectasis
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine has been evaluated in patients with bronchiectasis, with promising results.

Insufficient Reliable Evidence To Rate Canker sores
Rating & evidence shown verbatim from Natural Medicines

It is unclear if rinsing the mouth with N-acetyl cysteine solution is beneficial in patients with canker sores.

Insufficient Reliable Evidence To Rate Chemotherapy-induced hepatotoxicity
Rating & evidence shown verbatim from Natural Medicines

It is unclear if intravenous N-acetyl cysteine is beneficial in patients with chemotherapy-induced hepatotoxicity. Oral N-acetyl cysteine has not been evaluated for this use.

Insufficient Reliable Evidence To Rate Chemotherapy-induced peripheral neuropathy
Rating & evidence shown verbatim from Natural Medicines

Small clinical studies suggest that oral N-acetyl cysteine may reduce the risk for peripheral neuropathy in patients receiving oxaliplatin.

Insufficient Reliable Evidence To Rate Chronic fatigue syndrome (CFS)
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral N-acetyl cysteine for CFS, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this purpose.

Insufficient Reliable Evidence To Rate Chronic kidney disease (CKD)
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine does not seem to improve kidney function in patients with CKD or reduce the risk of kidney injury or other complications after cardiac surgery in patients with CKD. However, intravenous N-acetyl cysteine might offer some benefit in patients with CKD undergoing cardiac surgery.

Insufficient Reliable Evidence To Rate Cocaine dependence
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is effective for reducing cravings or withdrawal symptoms in people trying to stop cocaine use.

Insufficient Reliable Evidence To Rate Colorectal cancer
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is effective for preventing colorectal cancer.

Insufficient Reliable Evidence To Rate Coronary artery bypass graft (CABG) surgery
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral or intravenous N-acetyl cysteine is beneficial in patients undergoing CABG surgery.

Insufficient Reliable Evidence To Rate Coronavirus disease 2019 (COVID-19)
Rating & evidence shown verbatim from Natural Medicines

Small clinical trials suggest that intravenous N-acetyl cysteine is not beneficial in patients at risk for respiratory failure from severe COVID-19. It is unclear if oral use is beneficial.

Insufficient Reliable Evidence To Rate Dental plaque
Rating & evidence shown verbatim from Natural Medicines

It is unclear if mouthwash solutions containing N-acetyl cysteine can reduce dental plaque; higher concentrations may be more effective than lower concentrations.

Insufficient Reliable Evidence To Rate Dry eye
Rating & evidence shown verbatim from Natural Medicines

Small clinical studies suggest that eye drops containing N-acetyl cysteine, with or without chitosan, might improve objective measures of dry eye.

Insufficient Reliable Evidence To Rate Endometriosis
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Esophagogastroduodenoscopy (EGD)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if N-acetyl cysteine (NAC) can improve visualization when used as a premedication for EGD.

Insufficient Reliable Evidence To Rate Exercise-induced muscle damage
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is effective for preventing or treating exercise-induced muscle damage.

Insufficient Reliable Evidence To Rate Fibrocystic breast disease
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is effective for fibrocystic beast disease.

Insufficient Reliable Evidence To Rate Gingivitis
Rating & evidence shown verbatim from Natural Medicines

It is unclear if mouthwash containing N-acetyl cysteine is effective for the prevention or treatment of gingivitis.

Insufficient Reliable Evidence To Rate Hangover
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral N-acetyl cysteine for treating hangovers, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this purpose.

Insufficient Reliable Evidence To Rate Hearing loss
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is effective for preventing or treating hearing loss.

Insufficient Reliable Evidence To Rate Hepatorenal syndrome
Rating & evidence shown verbatim from Natural Medicines

It is unclear if intravenous N-acetyl cysteine is beneficial in patients with hepatorenal syndrome. Oral N-acetyl cysteine has not been evaluated for this use.

Insufficient Reliable Evidence To Rate Hereditary hemorrhagic telangiectasia (HHT)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in patients with HHT.

Insufficient Reliable Evidence To Rate Idiopathic interstitial pneumonia
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral or inhaled N-acetyl cysteine is beneficial for the management of various forms of interstitial pneumonia.

Insufficient Reliable Evidence To Rate Lead toxicity
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral N-acetyl cysteine for lead toxicity, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this purpose.

Insufficient Reliable Evidence To Rate Malaria
Rating & evidence shown verbatim from Natural Medicines

It is unclear if intravenous N-acetyl cysteine is beneficial as an adjunct in treating malaria. Oral N-acetyl cysteine has not been evaluated for this use.

Insufficient Reliable Evidence To Rate Male infertility
Rating & evidence shown verbatim from Natural Medicines

It is unclear of oral N-acetyl cysteine is beneficial for male infertility.

Insufficient Reliable Evidence To Rate Mercury toxicity
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using oral N-acetyl cysteine for mercury toxicity, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this purpose.

Insufficient Reliable Evidence To Rate Miscarriage
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine has only been evaluated in combination with other ingredients; its benefit when used alone is unclear.

Insufficient Reliable Evidence To Rate Multiple sclerosis (MS)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral and intravenous N-acetyl cysteine are beneficial in patients with MS.

Insufficient Reliable Evidence To Rate Nitrate tolerance
Rating & evidence shown verbatim from Natural Medicines

Intravenous N-acetyl cysteine seems to reduce the development of nitrate tolerance. Oral N-acetyl cysteine has shown mixed results for this use.

Insufficient Reliable Evidence To Rate Nonalcoholic steatohepatitis (NASH)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in patients with NASH.

Insufficient Reliable Evidence To Rate Obsessive-compulsive disorder (OCD)
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine might improve some symptoms of OCD when used with fluvoxamine in adults. Its effects when used in combination with other psychiatric medications or as monotherapy in children and adults is unclear.

Insufficient Reliable Evidence To Rate Otitis media
Rating & evidence shown verbatim from Natural Medicines

Although there has been interest in using ear drops containing N-acetyl cysteine for otitis media, there is insufficient reliable information about the clinical effects of N-acetyl cysteine for this purpose.

Insufficient Reliable Evidence To Rate Polycystic ovary syndrome (PCOS)
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine might improve pregnancy-related outcomes in PCOS, although it appears to be less effective than metformin. Evidence on its benefits for other symptoms of PCOS is conflicting.

Insufficient Reliable Evidence To Rate Post-traumatic stress disorder (PTSD)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in veterans with PTSD.

Insufficient Reliable Evidence To Rate Postmenopausal conditions
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial for preventing postmenopausal bone loss.

Insufficient Reliable Evidence To Rate Preterm labor
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial for reducing the risk for preterm labor.

Insufficient Reliable Evidence To Rate Radiation-induced sialadenitis
Rating & evidence shown verbatim from Natural Medicines

It is unclear if mouthwash containing N-acetyl cysteine is beneficial for reducing dry mouth during chemoradiotherapy.

Insufficient Reliable Evidence To Rate Schizophrenia
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine seems to improve negative symptoms of schizophrenia. The benefits of N-acetyl cysteine on positive symptoms of schizophrenia are less clear.

Insufficient Reliable Evidence To Rate Sepsis
Rating & evidence shown verbatim from Natural Medicines

Small clinical studies suggest that intravenous N-acetyl cysteine may improve respiratory function and tissue oxygenation, but not mortality, in patients with septic shock.

Insufficient Reliable Evidence To Rate Sjogren syndrome
Rating & evidence shown verbatim from Natural Medicines

Small clinical studies suggest that oral N-acetyl cysteine may improve ocular and oral manifestations of this condition.

Insufficient Reliable Evidence To Rate Systemic lupus erythematosus (SLE)
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in patients with SLE.

Insufficient Reliable Evidence To Rate Thrombocytopenia
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine has only been evaluated in combination with other ingredients, its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Tourette syndrome
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in patients with this condition.

Insufficient Reliable Evidence To Rate Trichotillomania
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine might offer some benefit to adults, but not children, with trichotillomania.

Insufficient Reliable Evidence To Rate Ulcerative colitis
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in patients with ulcerative colitis.

Insufficient Reliable Evidence To Rate Urinary tract infections (UTIs)
Rating & evidence shown verbatim from Natural Medicines

Oral N-acetyl cysteine has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Insufficient Reliable Evidence To Rate Uterine fibroids
Rating & evidence shown verbatim from Natural Medicines

It is unclear if oral N-acetyl cysteine is beneficial in patients with uterine fibroids.

Insufficient Reliable Evidence To Rate Wound healing
Rating & evidence shown verbatim from Natural Medicines

It is unclear if postoperative intravenous N-acetyl cysteine is beneficial in patients undergoing lower extremity amputation.

Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.

Safety & precautions

NAC is generally well tolerated for most healthy adults when taken at recommended supplement doses. However, you should talk with a pharmacist or doctor before starting it, especially if you have a health condition or take other medicines.

People with asthma should be cautious, as inhaled forms can sometimes trigger airway tightening. Those with a history of stomach ulcers or bleeding disorders should also use care.

For pregnancy and breastfeeding, there is not enough reliable information about supplement use, so we recommend caution and a conversation with your doctor before taking it. NAC has been used in hospital settings during pregnancy under medical supervision, but that is different from self-treating with a supplement.

Side effects

The most common side effects are digestive, including nausea, vomiting, diarrhea, and stomach upset. NAC can also have an unpleasant sulfur-like smell or taste.

Less commonly, some people notice headache, drowsiness, or a stuffy or runny nose. Rarely, allergic-type reactions such as rash, itching, or trouble breathing can occur — this is more likely with the inhaled or injected hospital forms. If you have any signs of a serious reaction, stop using it and seek medical care.

N-acetyl Cysteine (nac): Reported Adverse Effects

Documented safety reports on N-acetyl Cysteine (nac) from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.

Orally, intravenously, and as an inhalation, N-acetyl cysteine is generally well-tolerated when used in typical doses. Most adverse effects to N-acetyl cysteine occur when single doses of greater than 9 grams are used or when a regimen of greater than 30 grams daily is followed.

Most Common Adverse Effects:

Orally: Diarrhea, dry mouth, dyspepsia, heartburn, loss of appetite, nausea, and vomiting.

Intravenously: Skin rash and hypersensitivity reactions.

Inhaled: Bronchospasm, cough, epigastric pain, throat irritation, and wheezing.

Serious Adverse Effects (Rare):

Orally: Chest tightness, hemoptysis, and palpitations have been reported.

Intravenously: Anaphylaxis, angina, dystonic reactions, tachycardia, and transient sinus bradycardia have been reported.

Reports by condition
Acetaminophen poisoning Hematologic

In general, hematologic adverse reactions are reported more frequently with intravenous N-acetyl cysteine compared with oral use. In surgical patients, decreased prothrombin time, prolonged coagulation time, increased blood loss, and decreased platelet aggregation have been reported after administration of IV N-acetyl cysteine. In one clinical trial, six healthy patients were administered a loading dose of IV N-acetyl cysteine 10 mg/kg followed by 10 mg/kg per hour for 32 hours. All patients experienced a decrease in prothrombin time by 30% to 40%. The decrease prothrombin time (25.4 sec to 20.6 sec) reached a steady state after 16 hours. In a clinical trial evaluating patients with acute myocardial infarction, hemorrhage occurred in three patients taking intravenous N-acetyl cysteine 10 mg/min, heparin (per study protocol), and aspirin. Two pediatric patients receiving intravenous N-acetyl cysteine (loading dose: 140 mg/kg followed by 70 mg/kg) experienced episodes of coagulopathy; however, patients were being treated for acetaminophen overdose.

Hemoptysis was reported in six patients receiving 200 mg of N-acetyl cysteine orally twice daily for 6 months for treatment of chronic bronchitis.

  1. Jepsen S, Hansen AB. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 1994;54:543-7.
  2. Niemi, T. T., Munsterhjelm, E., Poyhia, R., Hynninen, M. S., and Salmenpera, M. T. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagul.Fibrinolysis 2006;1
  3. Wijeysundera, D. N., Karkouti, K., Rao, V., Granton, J. T., Chan, C. T., Raban, R., Carroll, J., Poonawala, H., and Beattie, W. S. N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Me
  4. Arstall MA, Yang J, Stafford I, et al. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995;92:2855-62.
  5. Perry, H. E. and Shannon, M. W. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998;132(1):149-152.
  6. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study. Eur.J Respir.Dis.Suppl 1980;111:93-108.
Acute bronchitis Musculoskeletal
Amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) Neurologic/CNS

Orally, headache has been frequently reported with N-acetyl cysteine in clinical research. Other less common adverse effects reported in patients taking oral N-acetyl cysteine at a total daily dose of 600-1200 mg include dizziness, tiredness, vivid dreams, disorientation, and inability to concentrate. One pediatric patient receiving oral N-acetyl cysteine (loading dose: 140 mg/kg followed by 70 mg/kg) experienced encephalopathy.

Intravenously, N-acetyl cysteine has been associated with rare neurologic adverse reactions , including headache, lightheadedness, and dystonic reactions. In a previously healthy 2-year-old female, status epilepticus occurred during intravenous N-acetyl cysteine therapy for paracetamol ingestion. Increased deterioration in bulbar function in patients with amyotrophic lateral sclerosis has also been reported with IV N-acetyl cysteine.

  1. Estensen RD, Levy M, Klopp SJ, et al. N-acetylcysteine suppression of the proliferative index in the colon of patients with previous adenomatous colonic polyps. Cancer Lett 1999;147:109-14.
  2. Oldemeyer JB, Biddle WP, Wurdeman RL, et al. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Am Heart J 2003;146:E23. .
  3. Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., and Herzenberg, L. A. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl.Acad.Sci U.S.A 3-21-2006;103(12):4628-463
  4. Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., and Bush, A. I. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry 9-15-2008;64(6)
  5. Rasmussen, J. B. and Glennow, C. Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis. Eur.Respir.J 1988;1(4):351-355.
  6. Miller, L. F. and Rumack, B. H. Clinical safety of high oral doses of acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):76-85.
  7. Tattersall, A. B., Bridgman, K. M., and Huitson, A. Irish general practice study of acetylcysteine (Fabrol) in chronic bronchitis. J Int Med Res 1984;12(2):96-101.
  8. Tattersall, A. B., Bridgman, K. M., and Huitson, A. Acetylcysteine (Fabrol) in chronic bronchitis--a study in general practice. J Int Med Res 1983;11(5):279-284.
  9. Hansen, N. C., Skriver, A., Brorsen-Riis, L., Balslov, S., Evald, T., Maltbaek, N., Gunnersen, G., Garsdal, P., Sander, P., Pedersen, J. Z., and . Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchiti
  10. Jackson, I. M., Barnes, J., and Cooksey, P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. J Int Med Res 1984;12(3):198-206.
  11. Parr, G. D. and Huitson, A. Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis. Br.J.Dis.Chest 1987;81(4):341-348.
  12. Gray KM, Carpenter MJ, Baker NL, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169(8):805-12.
  13. Walters, M. T., Rubin, C. E., Keightley, S. J., Ward, C. D., and Cawley, M. I. A double-blind, cross-over, study of oral N-acetylcysteine in Sjogren's syndrome. Scand J Rheumatol.Suppl 1986;61:253-258.
  14. Perry, H. E. and Shannon, M. W. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998;132(1):149-152.
  15. Arstall MA, Yang J, Stafford I, et al. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995;92:2855-62.
  16. Reid, M. B., Stokic, D. S., Koch, S. M., Khawli, F. A., and Leis, A. A. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 1994;94(6):2468-2474.
  17. Hershkovitz, E., Shorer, Z., Levitas, A., and Tal, A. Status epilepticus following intravenous N-acetylcysteine therapy. Isr.J Med Sci 1996;32(11):1102-1104.
  18. Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52:559-64.
Angina Cardiovascular

Intravenously, N-acetyl cysteine has been reported to significantly increase systolic and diastolic blood pressure after exposure to nitroglycerin when compared with placebo. Tachycardia, chest pain, angina, and transient sinus bradycardia have been rarely reported after administration of intravenous N-acetyl cysteine.

Intratracheally, infants receiving 5% N-acetyl cysteine every four hours for chronic lung disease have developed bradycardia.

Orally, palpitations and chest tightness have been reported rarely in clinical research evaluating oral N-acetyl cysteine at doses up to 600 mg twice daily.

  1. Iversen HK. N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther 1992;52:125-33.
  2. Arstall MA, Yang J, Stafford I, et al. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995;92:2855-62.
  3. Dawson, A. H., Henry, D. A., and McEwen, J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust. 3-20-1989;150(6):329-331.
  4. Bibi, H., Seifert, B., Oullette, M., and Belik, J. Intratracheal N-acetylcysteine use in infants with chronic lung disease. Acta Paediatr. 1992;81(4):335-339.
  5. Parr, G. D. and Huitson, A. Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis. Br.J.Dis.Chest 1987;81(4):341-348.
  6. Jackson, I. M., Barnes, J., and Cooksey, P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. J Int Med Res 1984;12(3):198-206.
  7. Hansen, N. C., Skriver, A., Brorsen-Riis, L., Balslov, S., Evald, T., Maltbaek, N., Gunnersen, G., Garsdal, P., Sander, P., Pedersen, J. Z., and . Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchiti
Chemotherapy-induced phlebitis Other
Common cold Pulmonary/Respiratory

Respiratory adverse reactions to N-acetyl cysteine are most commonly reported with inhalable dosage forms. These include wheezing, bronchospasm, and cough. While less frequent, wheezing, bronchospasm, increased sputum production, cough, decreased peak flow, dyspnea, and cold symptoms have been reported with oral N-acetyl cysteine in clinical research. A few cases of wheezing, cough, and bronchospasm have also been reported with intravenous N-acetyl cysteine. Additionally, respiratory arrest has been reported in one case where a 16 year-old female was being treated for acetaminophen toxicity with intravenous N-acetyl cysteine.

Two premature infants receiving 5% N-acetyl cysteine via intratracheal instillation for the treatment of chronic lung disease had an increased frequency of cyanotic spells.

  1. BERNSTEIN, I. L. and AUSDENMOORE, R. W. IATROGENIC BRONCHOSPASM OCCURRING DURING CLINICAL TRIALS OF A NEW MUCOLYTIC AGENT, ACETYLCYSTEINE. Dis.Chest 1964;46:469-473.
  2. Millman, M. and Grundon, W. Use of acetylcysteine in bronchial asthma and emphysema. J Asthma Res 1969;6(4):199-209.
  3. Dano, G. Bronchospasm caused by acetylcysteine in children with bronchial asthma. Acta Allergol. 1971;26(3):181-190.
  4. REAS, H. W. THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS. J Pediatr 1964;65:542-557.
  5. Howatt, W. F. and DeMuth, G. R. A double-blind study of the use of acetylcysteine in patients with cystic fibrosis. Univ Mich.Med Cent.J 1966;32(2):82-85.
  6. Kory, R. C., Hirsch, S. R., and Giraldo, J. Nebulization of N-acetylcysteine combined with a bronchodilator in patients with chronic bronchitis. A controlled study. Chest 1968;54(6):504-509.
  7. Parr, G. D. and Huitson, A. Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis. Br.J.Dis.Chest 1987;81(4):341-348.
  8. Behr J, Maier K, Degenkolb B, et al. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997;156:1897-901.
  9. Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., and Herzenberg, L. A. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl.Acad.Sci U.S.A 3-21-2006;103(12):4628-463
  10. Boman, G., Backer, U., Larsson, S., Melander, B., and Wahlander, L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir.Dis 1983;64(6):405-415.
  11. Ho, S. W. and Beilin, L. J. Asthma associated with N-acetylcysteine infusion and paracetamol poisoning: report of two cases. Br Med J (Clin Res Ed) 9-24-1983;287(6396):876-877.
  12. Vale, J. A. and Buckley, B. M. Asthma associated with N-acetylcysteine infusion and paracetamol poisoning. Br Med J (Clin Res Ed) 10-22-1983;287(6400):1223.
  13. Reid, M. B., Stokic, D. S., Koch, S. M., Khawli, F. A., and Leis, A. A. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 1994;94(6):2468-2474.
  14. Dawson, A. H., Henry, D. A., and McEwen, J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust. 3-20-1989;150(6):329-331.
  15. Reynard, K., Riley, A., and Walker, B. E. Respiratory arrest after N-acetylcysteine for paracetamol overdose. Lancet 9-12-1992;340(8820):675.
  16. Bibi, H., Seifert, B., Oullette, M., and Belik, J. Intratracheal N-acetylcysteine use in infants with chronic lung disease. Acta Paediatr. 1992;81(4):335-339.
Constipation Gastrointestinal

Orally, gastrointestinal complaints are the most common adverse effects reported with N-acetyl cysteine. These include heartburn, dyspepsia, and epigastric pain. In one case report, esophagitis related to ulcerations occurred following intake of N-acetyl cysteine while in the supine position with inadequate water. Other common side effects include loss of appetite, flatulence, diarrhea, constipation, dry mouth, nausea, vomiting, gastric upset, acid reflux, changes in bowel habits, and intolerance to taste and odor. N-acetyl cysteine's unpleasant odor makes it difficult for some patients to take orally. Using a straw to drink N-acetyl cysteine solutions can improve tolerability. Additionally, placement of a nasogastric or duodenal tube and administration of metoclopramide or ondansetron can be helpful for patients unable to tolerate oral N-acetyl cysteine.

Intravenously, N-acetyl cysteine may cause diarrhea, dyspepsia, nausea, vomiting, mild gastrointestinal upset, and metallic taste.

When inhaled, N-acetyl cysteine may cause epigastric pain and throat irritation.

  1. Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., and Bush, A. I. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry 9-15-2008;64(6)
  2. Tattersall, A. B., Bridgman, K. M., and Huitson, A. Irish general practice study of acetylcysteine (Fabrol) in chronic bronchitis. J Int Med Res 1984;12(2):96-101.
  3. Jackson, I. M., Barnes, J., and Cooksey, P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. J Int Med Res 1984;12(3):198-206.
  4. Aylward, M., Maddock, J., and Dewland, P. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control. Eur.J Respir.Dis.Suppl 1980;111:81-89.
  5. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study. Eur.J Respir.Dis.Suppl 1980;111:93-108.
  6. Gray KM, Carpenter MJ, Baker NL, et al. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am J Psychiatry. 2012;169(8):805-12.
  7. van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung C
  8. Tattersall, A. B., Bridgman, K. M., and Huitson, A. Acetylcysteine (Fabrol) in chronic bronchitis--a study in general practice. J Int Med Res 1983;11(5):279-284.
  9. De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997;10:1535-41.
  10. Pela R, Calcagni AM, Subiaco S, et al. N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD. Respiration 1999;66:495-500..
  11. Wang W, Zhang Y, Liu Y, Xu L, Shi D. Severe chest pain due to N-acetylcysteine-induced esophagitis. Case Rep Med. 2019;2019:8057259.
  12. Nahir, A. M., Scharf, J. M., and Szargel, R. Effects of oral N-acetylcysteine on both ocular and oral manifestations of Sjogren's Syndrome. Curr Ther Res 1989;46:187-192.
  13. Wiklund O, Fager G, Andersson A, et al. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis 1996;119:99-106.
  14. Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., and Herzenberg, L. A. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl.Acad.Sci U.S.A 3-21-2006;103(12):4628-463
  15. Miller, L. F. and Rumack, B. H. Clinical safety of high oral doses of acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):76-85.
  16. Kranzer K, Elamin WF, Cox H, Seddon JA, Ford N, Drobniewski F. A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.
  17. Behr J, Maier K, Degenkolb B, et al. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997;156:1897-901.
  18. Oldemeyer JB, Biddle WP, Wurdeman RL, et al. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Am Heart J 2003;146:E23. .
  19. Komisarof, J. A., Gilkey, G. M., Peters, D. M., Koudelka, C. W., Meyer, M. M., and Smith, S. M. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON). Crit Care Med 2007;35(2):435-441.
  20. Costa DLC, Diniz JB, Requena G, et al. Randomized double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2017 Jul;78(7):e799-e773.
  21. Sarris J, Byrne G, Castle D, et al. N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 2022;117:110550
  22. Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
  23. Myers, C., Bonow, R., Palmeri, S., Jenkins, J., Corden, B., Locker, G., Doroshow, J., and Epstein, S. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):53-55.
  24. Reid, M. B., Stokic, D. S., Koch, S. M., Khawli, F. A., and Leis, A. A. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 1994;94(6):2468-2474.
  25. Monti DA, Zabrecky G, Leist TP, et al. N-acetyl cysteine administration is associated with increased cerebral glucose metabolism in patients with multiple sclerosis: An exploratory study. Front Neurol. 2020;11:88.
  26. Howatt, W. F. and DeMuth, G. R. A double-blind study of the use of acetylcysteine in patients with cystic fibrosis. Univ Mich.Med Cent.J 1966;32(2):82-85.
  27. Millman, M. and Grundon, W. Use of acetylcysteine in bronchial asthma and emphysema. J Asthma Res 1969;6(4):199-209.
  28. Cato, A., Goldstein, I., and Millman, M. A double-blind parallel study of acetylcysteine-isoproterenol and saline-isoproterenol in patients with chronic obstructive lung disease. J Int Med Res 1977;5(3):175-183.
Erythema Dermatologic

Orally, N-acetyl cysteine may cause hives, flushing, and edema. Rash has also been reported. In one study, flushing was reported in 2% of patients receiving 600 mg of N-acetyl cysteine orally twice daily for six months.

Intravenously, N-acetyl cysteine may cause rash, and the occurrence seems to be more common than with oral use. Hives, facial edema, flushing, and pruritus have also been reported. In a small case series of 10 healthy male patients receiving 150 mg/kg of intravenous N-acetyl cysteine for muscle fatigue, erythema was experienced 30 minutes after infusion. Other side effects reported by these patients include facial erythema, palmar erythema, and sweating. In other clinical research, three patients developed an erythematous flare at the sites of previous venipunctures after receiving 5.5 gm/m2 of N-acetyl cysteine with doxorubicin therapy. Pain, inflammation, and excoriation of the skin have been reported after a 20% N-acetyl cysteine solution leaked from the catheter in one patient.

  1. Miller, L. F. and Rumack, B. H. Clinical safety of high oral doses of acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):76-85.
  2. Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study. Eur.J Respir.Dis.Suppl 1980;111:93-108.
  3. Charley, G., Dean, B. S., and Krenzelok, E. P. Oral N-acetylcysteine-induced urticaria: a case report. Vet.Hum Toxicol. 1987;29:477.
  4. De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997;10:1535-41.
  5. Tattersall, A. B., Bridgman, K. M., and Huitson, A. Irish general practice study of acetylcysteine (Fabrol) in chronic bronchitis. J Int Med Res 1984;12(2):96-101.
  6. Boman, G., Backer, U., Larsson, S., Melander, B., and Wahlander, L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir.Dis 1983;64(6):405-415.
  7. Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., and Herzenberg, L. A. High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc Natl.Acad.Sci U.S.A 3-21-2006;103(12):4628-463
  8. Jackson, I. M., Barnes, J., and Cooksey, P. Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study. J Int Med Res 1984;12(3):198-206.
  9. Li F, Welling MC, Johnson JA, et al. N-acetylcysteine for pediatric obsessive-compulsive disorder: A small pilot study. J Child Adolesc Psychopharmacol. 2020;30(1):32-37.
  10. Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52:559-64.
  11. Jepsen, S., Herlevsen, P., Knudsen, P., Bud, M. I., and Klausen, N. O. Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomized, placebo-controlled study. Crit Care Med 1992;20(7):918-923.
  12. Grimble, G. K. Adverse gastrointestinal effects of arginine and related amino acids. J Nutr 2007;137(6 Suppl 2):1693S-1701S.
  13. Dawson, A. H., Henry, D. A., and McEwen, J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust. 3-20-1989;150(6):329-331.
  14. Chan, T. Y. and Critchley, J. A. Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp.Toxicol. 1994;13(8):542-544.
  15. Perry, H. E. and Shannon, M. W. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998;132(1):149-152.
  16. Iversen HK. N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther 1992;52:125-33.
  17. Buckley, N. A., Whyte, I. M., O'Connell, D. L., and Dawson, A. H. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol.Clin Toxicol. 1999;37(6):759-767.
  18. Reid, M. B., Stokic, D. S., Koch, S. M., Khawli, F. A., and Leis, A. A. N-acetylcysteine inhibits muscle fatigue in humans. J Clin Invest 1994;94(6):2468-2474.
  19. Myers, C., Bonow, R., Palmeri, S., Jenkins, J., Corden, B., Locker, G., Doroshow, J., and Epstein, S. A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):53-55.
  20. Casola, G. and vanSonnenberg, E. Skin damage from acetylcysteine leak during percutaneous abscess drainage. Radiology 1984;152(1):233.
Hypotension Immunologic

Orally, anaphylaxis to N-acetyl cysteine has been rarely reported. However, anaphylactic reactions to intravenous N-acetyl cysteine appear to be more common.

Anaphylactic reactions to N-acetyl cysteine have involved rash, angioedema, hypotension, and bronchospasm. The mechanism of this reaction is unclear, but some data suggest it is not an immunologic hypersensitivity reaction but rather an acute toxic effect of N-acetyl cysteine. Management guidelines for the treatment of anaphylactoid reactions to intravenous N-acetyl cysteine have been published. In most cases, treatment is not required or treatment with diphenhydramine or salbutamol is sufficient to continue or restart N-acetyl cysteine infusion. Antihistamines are useful in controlling and preventing recurrence of anaphylactoid symptoms.

  1. Perry, H. E. and Shannon, M. W. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 1998;132(1):149-152.
  2. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998;31:710-5.
  3. Buckley, N. A., Whyte, I. M., O'Connell, D. L., and Dawson, A. H. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? J Toxicol.Clin Toxicol. 1999;37(6):759-767.
  4. Sunman, W., Hughes, A. D., and Sever, P. S. Anaphylactoid response to intravenous acetylcysteine. Lancet 5-16-1992;339(8803):1231-1232.
  5. Nigwekar, S. U. and Kandula, P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac.Surg 2009;87(1):139-147.
  6. Vale, J. A. and Wheeler, D. C. Anaphylactoid reaction to acetylcysteine. Lancet 10-30-1982;2(8305):988.
  7. Mant, T. G., Tempowski, J. H., Volans, G. N., and Talbot, J. C. Adverse reactions to acetylcysteine and effects of overdose. Br Med J (Clin Res Ed) 7-28-1984;289(6439):217-219.
  8. Gervais, S., Lussier-Labelle, F., and Beaudet, G. Anaphylactoid reaction to acetylcysteine. Clin Pharm 1984;3(6):586-587.
  9. Stavem, K. [Anaphylactic reaction to N-acetylcysteine after poisoning with paracetamol]. Tidsskr.Nor Laegeforen. 5-30-1997;117(14):2038-2039.
  10. Walton, N. G., Mann, T. A., and Shaw, K. M. Anaphylactoid reaction to N-acetylcysteine. Lancet 12-15-1979;2(8155):1298.
  11. Bateman, D. N., Woodhouse, K. W., and Rawlins, M. D. Adverse reactions to N-acetylcysteine. Hum Toxicol. 1984;3(5):393-398.
  12. Sandilands, E. A. and Bateman, D. N. Adverse reactions associated with acetylcysteine. Clin Toxicol.(Phila) 2009;47(2):81-88.
Myasthenia gravis Genitourinary

Orally, dysuria was reported in 2% of patients receiving 600 mg of N-acetyl cysteine twice daily for 6 months in one clinical trial.

  1. De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997;10:1535-41.
DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

Adverse-effects data: Natural Medicines, Therapeutic Research Center

Dosing

There is no single standardized dose of NAC for general supplement use, and the right amount depends on why it is being used. Prescription uses, such as treating acetaminophen overdose, follow strict medical protocols and are handled only in a healthcare setting.

For over-the-counter supplements, follow the directions on the product label and do not exceed the recommended amount. Because doses and product quality can vary, it is a good idea to check with your pharmacist or doctor to find what is appropriate for you.

Pregnancy & Breastfeeding

N-acetyl Cysteine (nac) & Breastfeeding

Insufficient reliable information

Insufficient reliable information available; avoid using.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.

© 2026 Therapeutic Research Center

Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center

References & further reading

The 86 references that drive our N-acetyl Cysteine (nac) monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Ellenhorn MJ, et al. Ellenhorn's Medical Toxicology: Diagnoses and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams & Wilkins, 1997.
  2. Jepsen S, Hansen AB. The influence of N-acetylcysteine on the measurement of prothrombin time and activated partial thromboplastin time in healthy subjects. Scand J Clin Lab Invest 1994;54:543-7. PubMed
  3. van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung C DOI
  4. Horowitz RS, Dart RC, Jarvie DR, et al. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol 1997;35:447-51.
  5. Bailey B, McGuigan MA. Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998;31:710-5. PubMed
  6. Spiller HA, Krenzelok EP, Grande GA, et al. A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994;23:519-23. PubMed
  7. Ardissino D, Merlini PA, Savonitto S, et al. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. J Am Coll Cardiol 1997;29:941-7. PubMed
  8. Horowitz JD, Henry CA, Syrjanen ML, et al. Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris. Eur Heart J 1988;9:95-100. PubMed
  9. Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol 1995;52:559-64. PubMed
  10. Wiklund O, Fager G, Andersson A, et al. N-acetylcysteine treatment lowers plasma homocysteine but not serum lipoprotein(a) levels. Atherosclerosis 1996;119:99-106. PubMed
  11. De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 1997;10:1535-41. PubMed
  12. Iversen HK. N-acetylcysteine enhances nitroglycerin-induced headache and cranial arterial responses. Clin Pharmacol Ther 1992;52:125-33. PubMed
  13. Behr J, Maier K, Degenkolb B, et al. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997;156:1897-901.
  14. Tenenbein PK, Sitar DS, Tenenbein M. Interaction between N-acetylcysteine and activated charcoal: implications for the treatment of acetaminophen poisoning. Pharmacotherapy 2001;21:1331-6.
  15. Arstall MA, Yang J, Stafford I, et al. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects. Circulation 1995;92:2855-62.
Keep reading

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Product directory

Supplement products with N-acetyl Cysteine (nac)

3,570 products in our database contain N-acetyl Cysteine (nac). Open any to see its full ingredient list and every drug interaction we check.

1 Detoxify And Support by Renew Life Capsule 30 Capsule(s) View ingredients & interactions 1 Detoxify With Deep Liver And Organ Cleanse by Renew Life Capsule 14 Capsule(s) View ingredients & interactions 1650 mg Glutathione Complex by Relumins Advance White Capsule 90 Vegetarian Capsule(s) View ingredients & interactions 2-in-1 Kidney & Liver Super Cleanse by Irwin Naturals Softgel Capsule 60 Liquid Soft-Gel(s) View ingredients & interactions 4Life Transfer Factor Plus RiteStart Men by 4Life Unknown 30 Packet(s) View ingredients & interactions 4Sight by Ortho Molecular Products Capsule 120 Capsule(s) View ingredients & interactions 4Sight by Ortho Molecular Products Capsule 60 Capsule(s) View ingredients & interactions 50+ Men Multivitamin + Supporting Herbs Iron Free by Super Nutrition SimplyOne Tablet Or Pill 90 Tablet(s) View ingredients & interactions 50+ Men Multivitamin + Supporting Herbs Iron Free by Super Nutrition SimplyOne Tablet Or Pill 30 Tablet(s) View ingredients & interactions 50+ Women Multivitamin + Supporting Herbs by Super Nutrition SimplyOne Tablet Or Pill 90 Tablet(s) View ingredients & interactions 50+ Women's Daily by ecoNugenics Capsule 240 Vegetarian Capsule(s) View ingredients & interactions A.R.M.D. Eye Support by Douglas Laboratories Tablet Or Pill 60 Tablet(s) View ingredients & interactions A.R.M.D. Eye Support Beta by Douglas Laboratories Tablet Or Pill 50 Tablet(s) View ingredients & interactions A.R.M.D. Eye Support Beta by Douglas Laboratories Tablet Or Pill 60 Tablet(s) View ingredients & interactions Able Eyes by Carlson Softgel Capsule 180 Softgel(s) View ingredients & interactions Able Eyes by Carlson Softgel Capsule 60 Softgel(s) View ingredients & interactions Able Eyes by Carlson Softgel Capsule 90 Softgel(s) View ingredients & interactions Able Eyes by Carlson Softgel Capsule 30 Softgel(s) View ingredients & interactions Accell Therapeutic by Systemic Formulas Powder 920 Gram(s) View ingredients & interactions Accutrophin by Physician's Signature Capsule 60 Capsule(s) View ingredients & interactions AccuVision by Advanced Nutrition by Zahler Capsule 120 Capsule(s) View ingredients & interactions ACES Gold by Carlson Tablet Or Pill 180 Tablet(s) View ingredients & interactions ACES Gold by Carlson Tablet Or Pill 120 Tablet(s) View ingredients & interactions Acetyl L-Carnitine Alpha Lipoic Acid by Solaray Capsule 60 VegCap(s) View ingredients & interactions
Pharmacist Counseling Corner

N-acetyl Cysteine (nac): Common Questions

What is N-acetyl Cysteine (nac) used for, and does it work?
People use N-acetyl Cysteine (nac) for many reasons, but the evidence varies by use. According to the Natural Medicines database, there is at least some clinical evidence supporting N-acetyl Cysteine (nac) for Acetaminophen poisoning, Atelectasis, Bronchial diagnostic studies and Tracheostomy care. For most other uses it has been studied for, the evidence is currently insufficient to rate. See the graded list on this page, and always confirm with your pharmacist or doctor.
Does N-acetyl Cysteine (nac) interact with prescription medications?
Yes. We list 294 medications with a known interaction with N-acetyl Cysteine (nac), including 1 rated major. Use the checker above to see how N-acetyl Cysteine (nac) interacts with a specific drug.
How are N-acetyl Cysteine (nac) interactions rated?
Each interaction is graded major, moderate, or minor based on how clinically significant it is and the strength of the evidence behind it. Major interactions are the most serious and are best avoided, or used only under close professional supervision.
Is it safe to take N-acetyl Cysteine (nac) with my medications?
It depends on the specific medication. Some combinations are fine, while others call for monitoring, timing changes, or should be avoided. Check your exact drug above and confirm with your pharmacist or doctor before starting, stopping, or changing anything.
Where does this N-acetyl Cysteine (nac) interaction information come from?
Our interaction data is built on the Natural Medicines database — an evidence-graded reference for vitamins, herbs, and supplements — and is reviewed by licensed HelloPharmacist pharmacists, who may add clinical context.
What is NAC used for?
In hospitals, NAC is used to treat acetaminophen overdose and to thin thick mucus in some lung conditions. As a supplement, people take it for antioxidant and glutathione support, liver health, and respiratory wellness, though the evidence for many of these uses is limited.
Is NAC safe to take every day?
NAC is generally well tolerated at recommended supplement doses for most healthy adults. Still, it's best to check with a pharmacist or doctor before taking it long term, especially if you have a health condition.
Can I take NAC while pregnant or breastfeeding?
There is not enough reliable safety information for supplement use during pregnancy or breastfeeding, so we recommend caution and talking with your doctor first.
Does NAC help boost glutathione?
NAC provides cysteine, which your body uses to make glutathione, and studies suggest it can support glutathione levels. Whether this translates into noticeable health benefits for everyday users is still being studied.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Have a question about N-acetyl Cysteine (nac)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist